Metformin and Rosiglitazone: A Novel Therapy for Type 2 Diabetes (Paperback) (ISBN-13: 9786202094177)

Diabetes induced hyperglycemia contributes to coagulation activation and hypofibrinolysis, resulting in a procoagulant state that predisposes patients to thrombotic events. Long-term hyperglycemia activates thrombotic factors. This review aims at understanding the mechanisms by which diabetes affects the coagulation pathway. The effects of improved glycemic control on coagulation and fibrinolysis in type 2 diabetes has been demonstrated for different oral antidiabetic therapies, such as, metformin in combination with rosiglitazone. Understanding the mechanism by which diabetes influences the coagulation pathway will help to develop more treatment strategies to reduce thrombotic events. A must read by Physicians, Clinicians and Care Givers to diabetics.

Author: Michael Awo Okungbowa
ISBN-10: 6202094176
ISBN-13: 9786202094177
Publisher: LAP Lambert Academic Publishing
Language: English
Published: 10/29/2019
Pages: 80
Format: Paperback
Weight: 0.28lbs
Size: 9.00h x 6.00w x 0.19d